Wang ML et al, 2019
« Back to Glossary Index« Back to Glossary Index
Wang ML, Munoz J, Goy A, et al. KTE-X19, an anti-CD19 Chimeric Antigen Receptor (CAR) T cell therapy, in patients (pts) with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): results of the phase 2 ZUMA-2 study. Blood (ASH annual meeting abstracts) 2019;134:754. https://ash.confex.com/ash/2019/webprogram/Paper126064.html?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news